www.expressindia.com - Weather | Horoscope | Stocks | RSS
expressindia web city
HomeBlogsCricketAstrologyShopping TendersClassifieds Opinions Jobs Hotels
Sign In / Register | Archive
Expressindia » Story

Origin of most malignant brain tumour identified: Study

Font Size

Agencies

Posted: Aug 12, 2008 at 1703 hrs IST

Melbourne, August 12: Scientists have identified the origin of the most malignant type of brain tumour, a discovery they claim provides a new hope for developing better therapies against the cancer.

An international team has found that medulloblastomas, a brain tumour that occurs most often in children, originates from two types of cell -- multipotent neural stem cells (NSCs) and granule neuron precursors (GNPs).

NSCs are stem cells that can become most types of cell within the nervous system while GNPs are similar to stem cells but give rise to a type of cells called granule neurons.

“There was good evidence that either cell type could be the origin of medulloblastomas, but no one considered that both sets of evidence could be correct, and that these tumours could actually begin in two different cell types.

“Identifying the normal cell that gives rise to a tumour is important because it allows direct comparisons between tumour cells and their normal counterparts so that key differences and vulnerabilities in tumour can be identified.

“Also, recent studies suggest that cells resembling the original cell may persist in mature tumours and can be critical in ensuring its survival. If so, these cells would be an excellent target for treatment,” lead scientist Brandon Wainwright was quoted by the ‘Cancer Cell’ journal as saying.

Wainwright of Queensland University and colleagues at Duke University in the United States made their discovery by examining a gene called Patched which is involved in the regulation of both neural stem cells and GNPs. When the gene is inactivated, medulloblastomas develop.

However, when inactivation occurs, it happens in all cells, so there was no way of knowing in which cell the tumour had begun.

The team took advantage of an allele, or version, of Patched that allows inactivation of the gene in either GNPs or neural stem cells, and found that the tumours developed no matter in which cell Patched was inactivated.

The study could also have wider implications for treating other types of cancer, as the team also found that cancer doesn’t always originate in the same way.

“It has always been thought that cells had to mutate several times before becoming a tumour. In this study we found that some stem cells only needed to mutate once.

“They would not turn cancerous immediately, but once they had been given an instruction to turn into a specialised cell, the mutation would take hold and they would instead turn into a tumour,” Wainwright said.

Discuss this story on expressindia forums
Post Comments
Name* Email ID*
Subject* Country*
Message*
Characters remaining
 
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
I agree to the terms of use.

Latest News

Business

Showbiz

Sports

Union Budget: I-T limit raised; sops for poor and farmers

Key features of Union Budget 2009-2010

SC judge apologises for ‘Taliban’ remarks on Muslims

Past receipts: Pakistan still owes India Rs 300 crore

Oz laws to be made tougher to check racial assaults

Floods leave 5 lakh homeless in Assam

Loopholes galore in Dehradun Police's 'encounter' story

More
© 2009 The Indian Express Limited. All rights reserved
The Indian Express Group | Advertise With Us | Privacy Policy | Feedback | Work With Us | Site Map